Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSenior Regulatory News (SNR)

Share Price Information for Senior (SNR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 159.80
Bid: 158.60
Ask: 159.40
Change: -0.40 (-0.25%)
Spread: 0.80 (0.504%)
Open: 155.00
High: 160.20
Low: 155.00
Prev. Close: 160.20
SNR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Senior plc

9 Jun 2021 15:20

Aberforth Partners LLP - Form 8.3 - Senior plc

Aberforth Partners LLP - Form 8.3 - Senior plc

PR Newswire

London, June 9

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON

WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Aberforth Partners LLP, on behalf of discretionary clients.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Senior plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 08/06/2021
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”YES / NO / N/A NO If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary Shares
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled: 36,835,479 8.78% 0 0.0
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL: 36,835,479 8.78% 0 0.0

Aberforth Partners LLP does not have discretion regarding voting decisions in respect of 10,807,915 shares included in the total disclosed above. This total includes 10,807,915 shares held by The Wellcome Trust, who retain voting control over their shareholding. No other client, who falls into this category, holds more than 1% of the relevant security.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:N/A
Details, including nature of the rights concerned and relevant percentages:N/A

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
Ordinary Shares Sale 143,740  154.068p

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/A

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure: 09 June 2021
Contact name:Michael Campbell, for Aberforth Partners LLP
Telephone number:0131 220 0733

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
25th Mar 20147:00 amRNSDirector/PDMR Shareholding
18th Mar 20144:34 pmRNSDocuments available for inspection
17th Mar 20144:18 pmRNSAdditional Listing
14th Mar 20146:17 pmRNSDirector/PDMR Shareholding
10th Mar 20147:00 amRNSAcquisition
3rd Mar 20147:00 amRNSFinal Results
31st Jan 201412:36 pmRNSTotal Voting Rights
17th Jan 20145:00 pmRNSHolding(s) in Company
15th Jan 20145:49 pmRNSBlocklisting Interim Review
17th Dec 20136:16 pmRNSDirector/PDMR Shareholding
17th Dec 20136:15 pmRNSHolding(s) in Company
13th Dec 20135:44 pmRNSHolding(s) in Company
5th Dec 20136:05 pmRNSDirectorate Change
5th Dec 20136:05 pmRNSHolding(s) in Company
4th Dec 20132:19 pmRNSDirector/PDMR Shareholding
3rd Dec 20136:08 pmRNSHolding(s) in Company
2nd Dec 20137:00 amRNSAcquisition
21st Nov 20138:20 amRNSDirector/PDMR Shareholding
18th Nov 20136:16 pmRNSHolding(s) in Company
18th Nov 20136:15 pmRNSHolding(s) in Company
5th Nov 20136:24 pmRNSDirector/PDMR Shareholding
31st Oct 20135:01 pmRNSTotal Voting Rights
21st Oct 20137:00 amRNSInterim Management Statement
2nd Oct 20138:00 amRNSNotice of Change of Director's Details
24th Sep 20136:19 pmRNSHolding(s) in Company
5th Sep 20137:00 amRNSDirector/PDMR Shareholding
2nd Sep 20132:54 pmRNSConfirmation of Directors
29th Jul 20137:05 amRNSDirectorate Change
29th Jul 20137:00 amRNSHalf Yearly Report
16th Jul 20137:00 amRNSBlocklisting Interim Review
3rd Jul 201311:30 amRNSHolding(s) in Company
1st Jul 201311:43 amRNSTotal Voting Rights
19th Jun 20135:58 pmRNSHolding(s) in Company
17th Jun 20135:43 pmRNSDirector/PDMR Shareholding
7th Jun 20134:54 pmRNSDirector/PDMR Shareholding
4th Jun 20139:52 amRNSNotice of Change of Director's Details
3rd Jun 201311:18 amRNSDirector/PDMR Shareholding
30th May 20136:28 pmRNSHolding(s) in Company
16th May 20134:44 pmRNSChange in Director Details
3rd May 201312:38 pmRNSTotal Voting Rights
3rd May 20138:09 amRNSDirector/PDMR Shareholding
1st May 20134:09 pmRNSDirector/PDMR Shareholding
1st May 20133:41 pmRNSChange in Director Details
29th Apr 20137:00 amRNSResult of AGM
25th Apr 20137:00 amRNSInterim Management Statement
22nd Apr 20136:14 pmRNSHolding(s) in Company
19th Apr 20139:11 amRNSHolding(s) in Company
19th Apr 20139:11 amRNSHolding(s) in Company
9th Apr 20131:20 pmRNSChange in Director Details
2nd Apr 20138:25 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.